Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Jang B-, Paik J-, Kim S-, Shin D-, Song D-, Park J-, et al. Catalase induced expression of inflammatory mediators via activation of NF-kappaB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. Cell Signal. 2005;17(5):625-33.

Fadare O, Qin L, Martel M, Tavassoli FA. Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system. Arch Pathol Lab Med. 2005;129(9):1175-8.

Gopalan A, Hoda SA. Columnar cell hyperplasia and lobular carcinoma in situ coexisting in the same duct. Breast J. 2005;11(3):210.

Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, et al. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn. 2005;7(3):413-21.

Gorlova O, Peng B, Yankelevitz D, Henschke C, Kimmel M. Estimating the growth rates of primary lung tumours from samples with missing measurements. Stat Med. 2005;24(7):1117-34.

Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, et al. Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol. 2005;23(22):5044-51.

Trocciola SM, Hoda S, Osborne MP, Christos PJ, Levin H, Martins D, et al. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients? J Am Coll Surg. 2005;200(5):720-5; discussion 725-6.

Magro CM, Sachdeva MP, A Crowson N, Barusevicius A, Baran PN, Kovatich AJ. The application of a monoclonal antibody to CD62L on paraffin-embedded tissue samples in the assessment of the cutaneous T-cell infiltrates. J Cutan Pathol. 2005;32(1):12-20.

Siddiqui MT, Gokaslan ST, M Saboorian H, Ashfaq R. Split sample comparison of ThinPrep and conventional smears in endoscopic retrograde cholangiopancreatography-guided pancreatic fine-needle aspirations. Diagn Cytopathol. 2005;32(2):70-5.

Peng W, Zhang X, Mohamed N, Inghirami G, Takeshita K, Pecora A, et al. A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation. Cancer Immunol Immunother. 2005;54(12):1172-9.